Late Breaker Sessions

Updates from NIH Office of Science Policy

February 9, 2016 | 7:15 a.m. – 8:00 a.m.

Moderator: Ryan Bayha; NIH, Bethesda, MD

Speaker: Carrie Wolinetz; NIH, Bethesda, MD

This session will feature timely updates on several high profile biosecurity and biosafety issues of interest to the attendees of the meeting. First, an update will be given on the gain-of-function deliberative process. The National Science Advisory Board for Biosecurity (NSABB) will be making their recommendations to the USG on a new policy governing this type of research in December 2015. During this session, NIH will go over the recommendations and discuss the next steps in the deliberative process, including how stakeholders can make their voices heard. Additionally, the session will provide an update on recent biosafety developments including the October 2015 recommendations of the Federal Experts Security Advisory Panel (FESAP)and the Fast-Track Action Committee on the Select Agent Regulations (FTAC-SAR). This session will be of special interest to attendees who work with agents subject to the gain-of-function pause and those who work with Select Agents.

 

FauciPhotoSpecial Session – Zika Virus: A Pandemic in Progress

February 10 | 7:15 a.m. – 8:00 a.m.

Moderator: Marshall Bloom; NIAID/NIH, Hamilton, MT

Speaker: Anthony Fauci, MD, Director, NIAID, Bethesda, MD

In 2015, an obscure mosquito-borne virus began spreading in the Western Hemisphere, causing a new pandemic. The little known Zika virus, a flavivirus in the same family as yellow fever, West Nile and dengue viruses, was first identified in Uganda in 1947; however, it received scant attention until the infection broke out massively in Latin America and the Caribbean and was associated with an abrupt increase in birth defects mostly in Brazilian newborns. Normally, a very mild disease, the infection also has been implicated in cases of Guillain-Barré syndrome. Since the initial reports in Brazil, the pandemic has spread rapidly to more than 24 countries and territories in the Americas. ASM is privileged to host National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, M.D. for a presentation entitled “Zika Virus: A Pandemic in Progress.”  Dr. Fauci will discuss the history of Zika virus, the current pandemic, and the biomedical research response, including diagnostic, therapeutics and vaccine development.

Search